Determination of Protein-Protein Interactions in a Mixture of Two Monoclonal Antibodies

Mol Pharm. 2019 Dec 2;16(12):4775-4786. doi: 10.1021/acs.molpharmaceut.9b00430. Epub 2019 Nov 11.

Abstract

The coformulation of monoclonal antibody (mAb) mixtures provides an attractive route to achieving therapeutic efficacy where the targeting of multiple epitopes is necessary. Controlling and predicting the behavior of such mixtures requires elucidating the molecular basis for the self- and cross-protein-protein interactions and how they depend on solution variables. While self-interactions are now beginning to be well understood, systematic studies of cross-interactions between mAbs in solution do not exist. Here, we have used static light scattering to measure the set of self- and cross-osmotic second virial coefficients in a solution containing a mixture of two mAbs, mAbA and mAbB, as a function of ionic strength and pH. mAbB exhibits strong association at a low ionic strength, which is attributed to an electrostatic attraction that is enhanced by the presence of a strong short-ranged attraction of nonelectrostatic origin. Under all solution conditions, the measured cross-interactions are intermediate self-interactions and follow similar patterns of behavior. There is a strong electrostatic attraction at higher pH values, reflecting the behavior of mAbB. Protein-protein interactions become more attractive with an increasing pH due to reducing the overall protein net charges, an effect that is attenuated with an increasing ionic strength due to the screening of electrostatic interactions. Under moderate ionic strength conditions, the reduced cross-virial coefficient, which reflects only the energetic contribution to protein-protein interactions, is given by a geometric average of the corresponding self-coefficients. We show the relationship can be rationalized using a patchy sphere model, where the interaction energy between sites i and j is given by the arithmetic mean of the i-i and j-j interactions. The geometric mean does not necessarily apply to all mAb mixtures and is expected to break down at a lower ionic strength due to the nonadditivity of electrostatic interactions.

Keywords: biopharmaceutical formulations; electrostatics; monoclonal antibody; osmotic second virial coefficients; protein−protein interactions.

MeSH terms

  • Antibodies, Monoclonal / metabolism*
  • Humans
  • Hydrogen-Ion Concentration
  • Light
  • Osmolar Concentration
  • Protein Binding / physiology
  • Protein Interaction Domains and Motifs / physiology*
  • Scattering, Radiation
  • Solutions / chemistry
  • Static Electricity

Substances

  • Antibodies, Monoclonal
  • Solutions